However, systemic administration of anti-4-1BB agonistic Abs is unsuccessful in correcting the defect in response to severe influenza in 4-1BBL-deficient mice, which is possibly because anti-4-1BB can target many cell types and lead to high levels of cytokine production and immunopathology [18,19]. Here, TNFRSF9 is linked to influenza.